Literature DB >> 25732382

Host age is a systemic regulator of gene expression impacting cancer progression.

Afshin Beheshti1, Sébastien Benzekry2, J Tyson McDonald1, Lili Ma1, Michael Peluso1, Philip Hahnfeldt1, Lynn Hlatky3.   

Abstract

Aging is the major determinant of cancer incidence, which, in turn, is likely dictated in large part by processes that influence the progression of early subclinical (occult) cancers. However, there is little understanding of how aging informs changes in aggregate host signaling that favor cancer progression. In this study, we provide direct evidence that aging can serve as an organizing axis to define cancer progression-modulating processes. As a model system to explore this concept, we employed adolescent (68 days), young adult (143 days), middle-aged (551 days), and old (736 days) C57BL/6 mice as syngeneic hosts for engraftment of Lewis lung cancer to identify signaling and functional processes varying with host age. Older hosts exhibited dysregulated angiogenesis, metabolism, and apoptosis, all of which are associated with cancer progression. TGFβ1, a central player in these systemic processes, was downregulated consistently in older hosts. Our findings directly supported the conclusion of a strong host age dependence in determining the host tumor control dynamic. Furthermore, our results offer initial mechanism-based insights into how aging modulates tumor progression in ways that may be actionable for therapy or prevention. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25732382      PMCID: PMC4397972          DOI: 10.1158/0008-5472.CAN-14-1053

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

Review 1.  Apoptosis in the aging process.

Authors:  Y Higami; I Shimokawa
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

Review 2.  Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

Authors:  Lynn Hlatky; Philip Hahnfeldt; Judah Folkman
Journal:  J Natl Cancer Inst       Date:  2002-06-19       Impact factor: 13.506

Review 3.  Stems cells and the pathways to aging and cancer.

Authors:  Derrick J Rossi; Catriona H M Jamieson; Irving L Weissman
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

Review 4.  DNA damage checkpoints in stem cells, ageing and cancer.

Authors:  Tobias Sperka; Jianwei Wang; K Lenhard Rudolph
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09       Impact factor: 94.444

Review 5.  TGF-beta biology in mammary development and breast cancer.

Authors:  Harold Moses; Mary Helen Barcellos-Hoff
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

6.  Transfer of age-associated restrained tumor growth in mice by old-to-young bone marrow transplantation.

Authors:  W B Ershler; A L Moore; H Shore; R L Gamelli
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

7.  Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.

Authors:  Jonine D Figueroa; Kathleen C Flanders; Montserrat Garcia-Closas; William F Anderson; Xiaohong R Yang; Rayna K Matsuno; Máire A Duggan; Ruth M Pfeiffer; Akira Ooshima; Robert Cornelison; Gretchen L Gierach; Louise A Brinton; Jolanta Lissowska; Beata Peplonska; Lalage M Wakefield; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2009-11-24       Impact factor: 4.872

8.  Mortality of atomic bomb survivors predicted from laboratory animals.

Authors:  Bruce A Carnes; Douglas Grahn; David Hoel
Journal:  Radiat Res       Date:  2003-08       Impact factor: 2.841

9.  Deficient tumor-specific immunity in old mice: in vivo mediation by suppressor cells, and correction of the defect by interleukin 2 supplementation in vitro but not in vivo.

Authors:  M Bruley-Rosset; B Payelle
Journal:  Eur J Immunol       Date:  1987-03       Impact factor: 5.532

10.  A perspective on new immune adjuvant principles: Reprogramming inflammatory states to permit clearance of cancer cells and other age-associated cellular pathologies.

Authors:  George C Prendergast; Richard Metz
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

View more
  20 in total

1.  Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.

Authors:  Dashnamoorthy Ravi; Afshin Beheshti; Nasséra Abermil; Frank Passero; Jaya Sharma; Michael Coyle; Athena Kritharis; Irawati Kandela; Lynn Hlatky; Michail V Sitkovsky; Andrew Mazar; Ronald B Gartenhaus; Andrew M Evens
Journal:  Cancer Res       Date:  2016-03-17       Impact factor: 12.701

2.  Environmental Enrichment Mitigates Age-Related Metabolic Decline and Lewis Lung Carcinoma Growth in Aged Female Mice.

Authors:  Nicholas J Queen; Hong Deng; Wei Huang; Xiaokui Mo; Ryan K Wilkins; Tao Zhu; Xiaoyu Wu; Lei Cao
Journal:  Cancer Prev Res (Phila)       Date:  2021-09-17

3.  Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.

Authors:  Diamantis I Tsilimigras; Kota Sahara; Lu Wu; Dimitrios Moris; Fabio Bagante; Alfredo Guglielmi; Luca Aldrighetti; Matthew Weiss; Todd W Bauer; Sorin Alexandrescu; George A Poultsides; Shishir K Maithel; Hugo P Marques; Guillaume Martel; Carlo Pulitano; Feng Shen; Olivier Soubrane; B Groot Koerkamp; Amika Moro; Kazunari Sasaki; Federico Aucejo; Xu-Feng Zhang; Ryusei Matsuyama; Itaru Endo; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2020-09-01       Impact factor: 14.766

4.  The Impact of Age and Sex in DLBCL: Systems Biology Analyses Identify Distinct Molecular Changes and Signaling Networks.

Authors:  Afshin Beheshti; Donna Neuberg; J Tyson McDonald; Charles R Vanderburg; Andrew M Evens
Journal:  Cancer Inform       Date:  2015-12-10

5.  A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma.

Authors:  Afshin Beheshti; Charles Vanderburg; J Tyson McDonald; Charusheila Ramkumar; Tatenda Kadungure; Hong Zhang; Ronald B Gartenhaus; Andrew M Evens
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

6.  Dynamic Analysis of Human Natural Killer Cell Response at Single-Cell Resolution in B-Cell Non-Hodgkin Lymphoma.

Authors:  Saheli Sarkar; Pooja Sabhachandani; Dashnamoorthy Ravi; Sayalee Potdar; Sneha Purvey; Afshin Beheshti; Andrew M Evens; Tania Konry
Journal:  Front Immunol       Date:  2017-12-14       Impact factor: 7.561

7.  Global transcriptomic analysis suggests carbon dioxide as an environmental stressor in spaceflight: A systems biology GeneLab case study.

Authors:  Afshin Beheshti; Egle Cekanaviciute; David J Smith; Sylvain V Costes
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

8.  Capturing the Driving Role of Tumor-Host Crosstalk in a Dynamical Model of Tumor Growth.

Authors:  Sebastien Benzekry; Afshin Beheshti; Philip Hahnfeldt; Lynn Hlatky
Journal:  Bio Protoc       Date:  2015-11-05

9.  Proton irradiation impacts age-driven modulations of cancer progression influenced by immune system transcriptome modifications from splenic tissue.

Authors:  Justin Wage; Lili Ma; Michael Peluso; Clare Lamont; Andrew M Evens; Philip Hahnfeldt; Lynn Hlatky; Afshin Beheshti
Journal:  J Radiat Res       Date:  2015-08-07       Impact factor: 2.724

10.  Tumor-host signaling interaction reveals a systemic, age-dependent splenic immune influence on tumor development.

Authors:  Afshin Beheshti; Justin Wage; J Tyson McDonald; Clare Lamont; Michael Peluso; Philip Hahnfeldt; Lynn Hlatky
Journal:  Oncotarget       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.